Trinity Biotech plc (TRIB) is a renowned global developer and manufacturer of diagnostic products for clinical laboratory and point-of-care segments of the diagnostic market. The company was founded in 1992 and is headquartered in Bray, Ireland, from where it operates worldwide. Trinity Biotech was listed on the NASDAQ in 1996 and also on the IEX, an Irish stock exchange. The company prides itself in the diverse range of high-quality diagnostic kits it develops and distributes to improve the overall healthcare sector worldwide.
Trinity Biotech specializes in the development and management of both clinical laboratories and point-of-care testing devices. The company's product line ranges from test kits used in clinical labs to handheld devices used for near-patient testing. The array of diagnostic products covers infectious diseases, sexually transmitted diseases, diabetes, haemoglobin disorders, autoimmune, lotus diseases, cardiac arrest, and liver and intestine disorders, among others.
Trinity Biotech’s proficiency cuts across research, developing, manufacturing, and marketing these advanced diagnostic products, which includes molecular diagnostics like reagents and instruments. One of the prominent products, Premier Hb9210, measures the glycated haemoglobin (HbA1c), instrumental in diagnosing and monitoring diabetes. With various products approved by the FDA, the company also produces the Uni-Gold HIV test, a reliable, single-use immunoassay for HIV testing used worldwide.
One of the fundamental principles governing Trinity Biotech is advancing global health by delivering high-quality, affordable diagnostic products and services that meet the highest standards of performance, safety, and efficacy.
Trinity Biotech is also committed to scientific and technological innovation. The company has been consistently improving its product offering to keep up with the rapidly evolving diagnostic industry. The company has state-of-the-art facilities and competent personnel that contribute to its continuous growth.
The company's infrastructure supports a robust research and development arm, focusing on the innovation of new diagnostic techniques, adhering to quality manufacturing, and offering excellent technical support to ensure client satisfaction. They also have a rigorous quality control system that aligns with the industry's regulatory requirements.
The company's steadfast commitment to improving global health through innovative diagnostic solutions has made Trinity Biotech an essential player in the medical industry. Its diagnostic products have contributed significantly to the diagnosis and management of various diseases, thereby improving patient care and public health worldwide.